🆕Drugs and Clinical Candidates

The Drugs and Clinical Candidates widget provides a disease-centric view of drugs and clinical candidates with evidence for the disease, based on the Clinical Indications dataset.

A clinical indication consolidates all clinical reports sharing the same drug and disease into a single record, aggregating evidence across sources and development stages while preserving traceability to each contributing report.

For each drug/indication pair, the widget displays the maximum clinical stage reached across all contributing reports. This is determined by ranking harmonised clinical stage values from each clinical report, with one explicit rule: if at least one supporting report has a stage of Phase IV or Withdrawal, the maximum clinical stage is set to Approval, reflecting the assumption that marketing authorisation must have been reached before a post-marketing or withdrawal context can occur.

For a full description of the clinical stage categories and their ranking, see Clinical stage categories in the Clinical Report page.